Sex differences in medicine explained

Sex differences in medicine include sex-specific diseases or conditions which occur only in people of one sex due to underlying biological factors (for example, prostate cancer in males or uterine cancer in females); sex-related diseases, which are diseases that are more common to one sex (for example, breast cancer and systemic lupus erythematosus which occur predominantly in females);[1] and diseases which occur at similar rates in males and females but manifest differently according to sex (for example, peripheral artery disease).[2]

Sex differences should not be confused with gender differences. The US National Academy of Medicine recognizes sex differences as biological at the chromosomal and anatomical levels, whereas gender differences are based on self-representation and other factors including biology, environment and experience.[3] [4] That said, both biological and behavioural differences influence human health, and may do so differentially. Such factors can be inter-related and difficult to separate. Evidence-based approaches to sex and gender medicine try to examine the effects of both sex and gender as factors when dealing with medical conditions that may affect populations differently.[5] [3]

, over 10,000 articles had been published addressing sex and gender differences in clinical medicine and related literature. Sex and gender affect cardiovascular,[6] pulmonary[7] and autoimmune systems, gastroenterology,[8] [9] hepatology,[10] nephrology,[11] endocrinology,[12] [13] haematology,[14] neurology,[15] [16] [17] [18] pharmacokinetics, and pharmacodynamics.[19] [20] [5] [3]

Sexually transmitted infections, which have a significant probability of transmission through sexual contact, can be contracted by either sex. Their occurrence may reflect economic and social as well as biological factors, leading to sex differences in the transmission, prevalence, and disease burden of STIs.[21]

Historically, medical research has primarily been conducted using the male body as the basis for clinical studies. The findings of these studies have often been applied across the sexes, and healthcare providers have traditionally assumed a uniform approach in treating both male and female patients. More recently, medical research has started to understand the importance of taking sex into account as evidence increases that the symptoms and responses to medical treatment may be very different between sexes.[22]

Background

Females and males exhibit many differences in terms of risk of developing disease, receiving an accurate diagnosis, and responding to treatments. A patient's sex has been increasingly recognized as one of the most important modulators of clinical decision making.[23] Sex differences have been found across a broad range of disease areas, including many diseases which are sex-specific. The sex chromosome complement and sex hormone environment are known to be the primary constitutive difference between females and males.[24] The imbalance of gene expression between the X and Y chromosomes is present within virtually all cells in the human body. Sex hormones are crucial in body development and function and also thought to contribute to sex differences in some diseases.[25] It is suspected that many differences between the sexes are also influenced by social, environmental, and psychological factors which are difficult to tease apart from biological ones.[4]

Causes

Sex-related illnesses have various causes:[10]

Examples of sex-related illnesses and disorders in humans

Females

Examples of sex-related illnesses and disorders in human females:[5]

Males

Examples of sex-related illnesses and disorders in male humans:[5]

Reasons for sex differences in incidence and prevalence

Hypertension

Hypertension is a worldwide disease affecting the sexes.[80] Women are less frequently affected by high blood pressure . Since blood pressure rises in women after menopause,[81] this suggests that the cause of the sex-specific differences lies not only in possible external factors, such as lifestyle, but also in the sex hormones . It is likely due to sex hormones not external factors. One possible mechanism is the influence of the renin-angiotensin system (RAAS).[82]

Angiotensinogen (liver) is converted into angiotensin I (Ang I) by renin (kidney). Ang I is converted to angiotensin II (Ang II) by the angiotensin-converting enzyme (ACE). This binds to the Ang II type I receptor (A2T1), which causes vasoconstriction and water and sodium reabsorption in the kidneys, and in turn increases blood pressure.

Less well known is that Ang II can also bind to Ang II type II receptor (A2T2) or be converted by angiotensin-converting enzyme II (ACE II) into angiotensin III (Ang III), which binds to MAS receptors.[83] Both A2T2 and MAS receptors trigger vasodilation.[84] Animal experiments have shown that female ovariectomised mice treated chronically with testosterone have increased blood pressure (mean arterial pressure ~180mmHg) compared to female mice from the control group (~155mmHg).[85] This difference was reduced by ACE inhibition (enalapril (250 mg/L)) in both groups to a similar level (~115mmHg).[86] It can therefore be assumed that male androgens have an increasing influence (up to 25mmHg in middle blood pressure) on angiotensinogen.[87]

Autoimmune diseases (Sjögren's syndrome)

In autoimmune diseases, like Sjögren's syndrome (SS), the body produces hyperreactive autoantibodies against the salivary and lacrimal gland tissue. This results in symptoms like dry mouth and dry eyes.

The gender distribution in Sjögren's syndrome is heavily skewed towards women, with a ratio of 16:1 in the UK.[88] Various reasons have been suggested, but the evidence is not strong. One common reason is the hormonal differences between women and men. In women, estrogen dominates, as does the hormone progesterone during pregnancy. Androgens (e.g. testosterone) are only present in small quantities. In men, testosterone, an androgen, dominates, and estrogen is only present to a small extent. Estrogen stimulates the immune system more than androgens. Accordingly, it stands to reason that an autoimmune reaction, which is based on a hyperreactive immune sensitivity to autoantigens, can manifest itself much more easily in women.

In Sjögren's syndrome, B cells and interferons are of particular importance. Generally, hormone receptors are expressed on immune cells (e.g., B cells), such as the estrogen receptor (ER-alpha/ß) or the androgen receptor. These receptors are steroid hormone receptors, i.e., they influence gene expression in the nucleus of the immune cells.

Pregnancy, including hormonal changes, appears to increase the risk of developing SS and also exacerbate the course of the disease if it is already present. During pregnancy, more hormones than just estrogen are secreted that also have an immune system-stimulating effect, such as prolactin. So, an overstimulated immune system seems to be the result.

On the other hand, estrogen protects glandular cells and prevents them from cell death. Menopause causes a decreased level of hormones like estrogen and thus reduces the protective effect on glandular cell health. Increased apoptosis (cell death) and inflammatory effects on damaged and aged cells are the result. As a result, there is an increased level of autoantibodies against the glandular cells. Estrogen is important, but only in the right amount. The study showed that the prevalence of women developing SS after menopause is quite higher than before menopause. This leads to the assumption that the protective effect of estrogen on glandular tissue is more important than the stimulation effect on B cells for the development of SS.

Another study investigated the hormonal influence on the pathogenesis of autoimmune diseases, including SS. Female mice had their ovaries removed to investigate the effect of missing estrogen on the pathogenesis of SS.[89] In this study, low estrogen levels promoted apoptosis and the formation of apoptotic bodies and microparticles containing membrane antigens. These are recognized as pathogens via TLR (toll-like receptors) of the dendritic and B cells, which then secrete increased levels of INF alpha/ß and cytokines. These cytokines stimulate other immune cells (e.g., DC, T-cells), which can lead to autoreactivity and thus to an autoimmune reaction.

In men, the preliminary stage of testosterone, DHT (dihydrotestosterone), is synthesized from testosterone in one simple step. DHT has an anti-apoptotic effect on the glandular tissue. In women, DHEA (dehydroepiandrosterone) takes over this task. Synthesizing this product in women is much more complex and involves several steps that are difficult to ensure when estrogen levels are low (menopause, etc.). This might be another reason for increased apoptosis and the pathogenesis of SS in women compared to men.

Another key player in the pathogenesis of SS is INF1. It is stimulated by estrogen receptor interaction. INF1 ensures a higher level of autoantibodies and inflammatory cytokines. A study has shown that interferon type I and type II are more pronounced in women than in men. That might be a reason for the increased level of autoantibodies and prevalence of SS in women.

Androgens generally have stimulating effects on the production of the lipid layer in the tear film and oral mucosa. Androgens increase the level of integrins alpha1 and 2, which promote the differentiation of mesenchymal stem cells into acinar cells. In the absence of androgens, this differentiation and regulation are defective. In SS, the conversion of testosterone to DHT (in men) or DHEA (in women) in the lacrimal glands is defective. The enzymes are not functional. This means that the lipid layer, which is important for maintaining moisture in the mouth and on the eyes and providing protection against pathogens, is missing. This could be a leading reason for symptoms like dry mouth and dry eyes.

Another study investigated the effects of gene expression of the sex chromosomes.[90] Normally, one X chromosome is inhibited in women (Barr body). However, not completely. Some of the genes of the inhibited X chromosome are still (single or double) expressed, including genes relevant to the immune system. This is supposed to ensure better immunity, among other things, but also results in a higher risk of autoimmunity.

The study has shown that the prevalence of SS in triple-X individuals is 2.9 times higher than in healthy women and 41 times higher than in healthy men, despite physiological hormone levels. This suggests an involvement of the double gene expression of the 2nd X chromosome in the pathogenesis of SS, which could also affect XX genotype women. An explanation how the double gene expression, which can also be normal, can be manifesting investigated another study.

Another study investigated the influence of a long non coding RNA protein, called XIST, which is a leading factor of the double X chromosome expression.[91] XIST is only present in women where it is inactivating genes of the second “restoring” X chromosome. Dysfuncitonal XIST proteins seem to be a leading cause of higher prevalence of autoimmune diseases of women, so as in SS.

Furthermore, intestinal microbiome differences, elevated levels of certain miRNAs, and microchimerism during pregnancy are discussed and investigated as possible risk factors in the pathogenesis of SS.

See also

Notes and References

  1. Ngo ST, Steyn FJ, McCombe PA . Gender differences in autoimmune disease . Frontiers in Neuroendocrinology . 35 . 3 . 347–369 . August 2014 . 24793874 . 10.1016/j.yfrne.2014.04.004 . free .
  2. Barochiner J, Aparicio LS, Waisman GD . Challenges associated with peripheral arterial disease in women . Vascular Health and Risk Management . 10 . 115–128 . 2014 . 24648743 . 3956880 . 10.2147/vhrm.s45181 . free .
  3. Book: Oertelt-Prigione S, Regitz-Zagrosek V . Sex and Gender Aspects in Clinical Medicine . 2012 . Springer . 978-1-4471-6002-1.
  4. Book: Institute of Medicine (US) Committee on Understanding the Biology of Sex and Gender Differences. . Exploring the Biological Contributions to Human Health: Does Sex Matter? . Wizemann TM, Pardue ML . Washington (DC) . National Academies Press . 2001 . 25057540 . 978-0-309-07281-6 .
  5. Regitz-Zagrosek V . Sex and gender differences in health. Science & Society Series on Sex and Science . EMBO Reports . 13 . 7 . 596–603 . June 2012 . 22699937 . 3388783 . 10.1038/embor.2012.87 .
  6. Miller VM . Virginia M. Miller . Universality of sex differences in cardiovascular outcomes: where do we go from here? . European Heart Journal . 41 . 17 . 1697–9 . May 2020 . 32357237 . 7194182 . 10.1093/eurheartj/ehaa310 .
  7. Weatherald J, Riha RL, Humbert M . Sex and gender in lung health and disease: more than just Xs and Ys . European Respiratory Review . 30 . 162 . 210217 . December 2021 . 34750117 . 10.1183/16000617.0217-2021 . 9488524 . 243861859 . free .
  8. Greuter T, Manser C, Pittet V, Vavricka SR, Biedermann L . Gender Differences in Inflammatory Bowel Disease . english . Digestion . 101 . 1 . 98–104 . 2020 . 31995797 . 10.1159/000504701 . 210946741 . Official working group of the Swiss Society of Gastroenterology . free .
  9. van Kessel L, Teunissen D, Lagro-Janssen T . Sex-Gender Differences in the Effectiveness of Treatment of Irritable Bowel Syndrome: A Systematic Review . International Journal of General Medicine . 14 . 867–884 . March 2021 . 33758534 . 7979326 . 10.2147/IJGM.S291964 . free .
  10. Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, De Vries GJ, Epperson CN, Govindan R, Klein SL, Lonardo A, Maki PM, McCullough LD, Regitz-Zagrosek V, Regensteiner JG, Rubin JB, Sandberg K, Suzuki A . 6 . Sex and gender: modifiers of health, disease, and medicine . English . Lancet . 396 . 10250 . 565–582 . August 2020 . 32828189 . 7440877 . 10.1016/S0140-6736(20)31561-0 .
  11. Bairey Merz CN, Dember LM, Ingelfinger JR, Vinson A, Neugarten J, Sandberg KL, Sullivan JC, Maric-Bilkan C, Rankin TL, Kimmel PL, Star RA . 6 . Sex and the kidneys: current understanding and research opportunities . Nature Reviews. Nephrology . 15 . 12 . 776–783 . December 2019 . 31586165 . 7745509 . 10.1038/s41581-019-0208-6 .
  12. Bhargava A, Arnold AP, Bangasser DA, Denton KM, Gupta A, Hilliard Krause LM, Mayer EA, McCarthy M, Miller WL, Raznahan A, Verma R . 6 . Considering Sex as a Biological Variable in Basic and Clinical Studies: An Endocrine Society Scientific Statement . Endocrine Reviews . 42 . 3 . 219–258 . May 2021 . 33704446 . 8348944 . 10.1210/endrev/bnaa034 .
  13. Lauretta R, Sansone M, Sansone A, Romanelli F, Appetecchia M . Gender in Endocrine Diseases: Role of Sex Gonadal Hormones . International Journal of Endocrinology . 2018 . 4847376 . 21 October 2018 . 30420884 . 6215564 . 10.1155/2018/4847376 . free .
  14. Murphy WG . The sex difference in haemoglobin levels in adults - mechanisms, causes, and consequences . Blood Reviews . 28 . 2 . 41–47 . March 2014 . 24491804 . 10.1016/j.blre.2013.12.003 .
  15. Clayton JA . Sex influences in neurological disorders: case studies and perspectives . Dialogues in Clinical Neuroscience . 18 . 4 . 357–360 . December 2016 . 28179807 . 5286721 . 10.31887/DCNS.2016.18.4/jclayton .
  16. Book: Institute of Medicine . Sex Differences and Implications for Translational Neuroscience Research : Workshop Summary . 2011 . National Academies Press . Washington, DC . 978-0-309-16124-4. NBK53393.
  17. Rippon G, Eliot L, Genon S, Joel D . How hype and hyperbole distort the neuroscience of sex differences . PLOS Biology . 19 . 5 . e3001253 . May 2021 . 33970901 . 8136838 . 10.1371/journal.pbio.3001253 . free .
  18. Shansky RM, Murphy AZ . Considering sex as a biological variable will require a global shift in science culture . Nature Neuroscience . 24 . 4 . 457–464 . April 2021 . 33649507 . 10.1038/s41593-021-00806-8 . 232091204 .
  19. Zucker I, Prendergast BJ . Sex differences in pharmacokinetics predict adverse drug reactions in women . Biology of Sex Differences . 11 . 1 . 32 . June 2020 . 32503637 . 7275616 . 10.1186/s13293-020-00308-5 . free .
  20. Soldin OP, Mattison DR . Sex differences in pharmacokinetics and pharmacodynamics . Clinical Pharmacokinetics . 48 . 3 . 143–157 . 2009 . 19385708 . 3644551 . 10.2165/00003088-200948030-00001 .
  21. Madkan VK, Giancola AA, Sra KK, Tyring SK . Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases . Archives of Dermatology . 142 . 3 . 365–370 . March 2006 . 16549716 . 10.1001/archderm.142.3.365 .
  22. Mauvais-Jarvis F, Merz BN, Barnes PJ, Brinton RD, Carrero JJ, DeMeo DL, Vries GJ, Epperson CN, Govindan R, Klein SL, Lonardo A, Maki PM, McCullough LD, Regitz-Zagrosek V, Regensteiner SG, Rubin JB, Sandberg K, Suzuki A . 6 . Sex and gender: modifiers of health, disease, and medicine . The Lancet . 22 August 2020 . 396 . 10250 . 565–582 . 10.1016/S0140-6736(20)31561-0 . 32828189 . 7440877 .
  23. Legato . Marianne J. . Johnson . Paula A. . Manson . JoAnn E. . Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes . JAMA . 8 November 2016 . 316 . 18 . 1865–6 . 10.1001/jama.2016.13995. 27802499 .
  24. Miller . Leah R. . Marks . Cheryl . Becker . Jill B. . Hurn . Patricia D. . Chen . Wei-Jung . Woodruff . Teresa . McCarthy . Margaret M. . Sohrabji . Farida . Schiebinger . Londa . Wetherington . Cora Lee . Makris . Susan . Arnold . Arthur P. . Einstein . Gillian . Miller . Virginia M. . Sandberg . Kathryn . Maier . Susan . Cornelison . Terri L. . Clayton . Janine A. . Considering sex as a biological variable in preclinical research . The FASEB Journal . January 2017 . 31 . 1 . 29–34 . 10.1096/fj.201600781r. free . 27682203 . 6191005 .
  25. Maeng . Lisa Y. . Milad . Mohammed R. . Sex differences in anxiety disorders: Interactions between fear, stress, and gonadal hormones . Hormones and Behavior . 1 November 2015 . 76 . 106–117 . 10.1016/j.yhbeh.2015.04.002 . 25888456 . 4823998 . en . 0018-506X.
  26. News: Zimmermann KA . Reproductive System: Facts, Functions & Diseases . 11 November 2021 . Live Science . 22 March 2018. en.
  27. Web site: Male Breast Cancer Treatment. 2014. National Cancer Institute. https://web.archive.org/web/20140704182515/http://www.cancer.gov/cancertopics/pdq/treatment/malebreast/HealthProfessional. 4 July 2014. live. 29 June 2014. dmy-all.
  28. Reid BM, Permuth JB, Sellers TA . Epidemiology of ovarian cancer: a review . Cancer Biology & Medicine . 14 . 1 . 9–32 . February 2017 . 28443200 . 10.20892/j.issn.2095-3941.2016.0084 . 5365187 .
  29. Klein SL, Flanagan KL . Sex differences in immune responses . Nature Reviews. Immunology . 16 . 10 . 626–638 . October 2016 . 27546235 . 10.1038/nri.2016.90 . 2258164 . free .
  30. Alswat KA . Gender Disparities in Osteoporosis . Journal of Clinical Medicine Research . 9 . 5 . 382–7 . May 2017 . 28392857 . 5380170 . 10.14740/jocmr2970w .
  31. Rose NR, Bona C . Defining criteria for autoimmune diseases (Witebsky's postulates revisited) . Immunology Today . 14 . 9 . 426–430 . September 1993 . 8216719 . 10.1016/0167-5699(93)90244-F .
  32. Hayter SM, Cook MC . Updated assessment of the prevalence, spectrum and case definition of autoimmune disease . Autoimmunity Reviews . 11 . 10 . 754–765 . August 2012 . 22387972 . 10.1016/j.autrev.2012.02.001 .
  33. Franceschini . Anna . Fattore . Liana . Gender-specific approach in psychiatric diseases: Because sex matters . European Journal of Pharmacology . 5 April 2021 . 896 . 173895 . 10.1016/j.ejphar.2021.173895 . 33508283 . 231753879 . 23 December 2021 . en . 0014-2999.
  34. Sweeting H, Walker L, MacLean A, Patterson C, Räisänen U, Hunt K . Prevalence of eating disorders in males: a review of rates reported in academic research and UK mass media . International Journal of Men's Health . 14 . 2 . 2015 . 26290657 . 4538851 . 10.3149/jmh.1402.86 . 31 January 2024 --> .
  35. Stice E, Marti CN, Rohde P . Prevalence, incidence, impairment, and course of the proposed DSM-5 eating disorder diagnoses in an 8-year prospective community study of young women . Journal of Abnormal Psychology . 122 . 2 . 445–457 . May 2013 . 23148784 . 10.1037/a0030679 . 3980846 .
  36. Gagne DA, Von Holle A, Brownley KA, Runfola CD, Hofmeier S, Branch KE, Bulik CM . Eating disorder symptoms and weight and shape concerns in a large web-based convenience sample of women ages 50 and above: results of the Gender and Body Image (GABI) study . The International Journal of Eating Disorders . 45 . 7 . 832–844 . November 2012 . 22729743 . 10.1002/eat.22030 . 3459309 .
  37. Schaumberg K, Welch E, Breithaupt L, Hübel C, Baker JH, Munn-Chernoff MA, Yilmaz Z, Ehrlich S, Mustelin L, Ghaderi A, Hardaway AJ, Bulik-Sullivan EC, Hedman AM, Jangmo A, Nilsson IA, Wiklund C, Yao S, Seidel M, Bulik CM . 6 . The Science Behind the Academy for Eating Disorders' Nine Truths About Eating Disorders . European Eating Disorders Review . 25 . 6 . 432–450 . November 2017 . 28967161 . 5711426 . 10.1002/erv.2553 .
  38. Book: American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Publishing. 2013. 978-0-89042-555-8. 5th. Arlington, VA. 338–349.
  39. Hanamsagar . Richa . Bilbo . Staci D. . Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development . The Journal of Steroid Biochemistry and Molecular Biology . June 2016 . 160 . 127–133 . 10.1016/j.jsbmb.2015.09.039 . 26435451 . 4829467 . en.
  40. Zielonka D, Stawinska-Witoszynska B . Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease . Frontiers in Neurology . 11 . 571 . 2020 . 32733356 . 7358529 . 10.3389/fneur.2020.00571 . free .
  41. Fracas E, Costantino A, Vecchi M, Buoli M . Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences? . Int J Environ Res Public Health . 20 . 13 . 6255 . June 2023 . 37444101 . 10340762 . 10.3390/ijerph20136255 . free.
  42. Schmitt A, Malchow B, Hasan A, Falkai P . The impact of environmental factors in severe psychiatric disorders . Frontiers in Neuroscience . 8 . 19 . 19 . February 2014 . 24574956 . 3920481 . 10.3389/fnins.2014.00019 . free .
  43. Book: Diagnostic and statistical manual of mental disorders: DSM-5. 2013. American Psychiatric Publishing. 978-0-89042-555-8. 5th . 645, 663–6.
  44. Web site: Definition & Facts for Irritable Bowel Syndrome NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. 2019-07-04.
  45. Clauw DJ . Fibromyalgia: a clinical review . JAMA . 311 . 15 . 1547–55 . April 2014 . 24737367 . 10.1001/jama.2014.3266 .
  46. Mallampalli MP, Carter CL . Exploring sex and gender differences in sleep health: a Society for Women's Health Research Report . Journal of Women's Health . 23 . 7 . 553–562 . July 2014 . 24956068 . 4089020 . 10.1089/jwh.2014.4816 .
  47. Web site: Chronic fatigue syndrome. 21 February 2017. womenshealth.gov. 13 May 2019.
  48. Benarroch EE . Postural tachycardia syndrome: a heterogeneous and multifactorial disorder . Mayo Clinic Proceedings . 87 . 12 . 1214–25 . December 2012 . 23122672 . 3547546 . 10.1016/j.mayocp.2012.08.013 .
  49. Dworetzky . Barbara A. . Baslet . Gaston . Psychogenic Nonepileptic Seizures in Women . Seminars in Neurology . December 2017 . 37 . 6 . 624–631 . 10.1055/s-0037-1607971 . 29270935 . 11959147 . 1098-9021.
  50. Türe . H. Sabiha . Tatlidil . Işıl . Kiliçarslan . Esin . Akhan . Galip . Gender-Related Differences in Semiology of Psychogenic Non-Epileptic Seizures . Archives of Neuropsychiatry . September 2019 . 56 . 3 . 178–181 . 10.29399/npa.23420 . 31523142 . 6732800 . en.
  51. Asadi-Pooya . Ali A. . Homayoun . Maryam . Psychogenic nonepileptic seizures: The sex ratio trajectory across the lifespan . Seizure . 1 February 2020 . 75 . 63–65 . 10.1016/j.seizure.2019.12.017 . 31874361 . 209413248 . en . 1059-1311. free .
  52. Kruszka . Paul . Silberbach . Michael . The state of Turner syndrome science: Are we on the threshold of discovery? . American Journal of Medical Genetics Part C: Seminars in Medical Genetics . March 2019 . 181 . 1 . 4–6 . 10.1002/ajmg.c.31688 . 30790455 . 73499005 . [Turner Syndrome] is one of the most common genetic syndromes that occurs only in females....
  53. Web site: Prostate vs. testicular cancer: Similarities and differences . Medical News Today . 10 November 2021 . en . 25 October 2021.
  54. Web site: U.S. National Library of Medicine. https://web.archive.org/web/20071012095806/http://www.nlm.nih.gov/medlineplus/hemophilia.html. 12 October 2007. live. 2 December 2007.
  55. Migeon BR . Why females are mosaics, X-chromosome inactivation, and sex differences in disease . Gender Medicine . 4 . 2 . 97–105 . June 2007 . 17707844 . 10.1016/S1550-8579(07)80024-6 .
  56. Brown C . Patchwork women . Nature Genetics . September 2007 . 39 . 9 . 1043 . 10.1038/ng0907-1043 . 32145544 . free .
  57. Book: Migeon BR . Females are mosaics : X inactivation and sex differences in disease . 2014 . Oxford University Press . Oxford . 978-0-19-992753-1 . 2nd.
  58. Book: Doblhammer D, Gumà J . A Demographic Perspective on Gender, Family and Health in Europe . February 12, 2018 . Springer . 978-1-01-326907-3 . 78 . Oksuzyan A, Gumà J, Doblhammer D . Sex Differences in Health and Survival §Effects of Sex Hormones on the Immune System . https://books.google.com/books?id=MuBLDwAAQBAJ&pg=PA78 . 11 November 2021.
  59. Latimer . Caitlin S. . Keene . C. Dirk . Flanagan . Margaret E. . Hemmy . Laura S. . Lim . Kelvin O. . White . Lon R. . Montine . Kathleen S. . Montine . Thomas J. . Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies . Journal of Neuropathology and Experimental Neurology . 1 June 2017 . 76 . 6 . 458–466 . 10.1093/jnen/nlx030 . 28499012 . 6334750 . 1554-6578.
  60. Ullah . Mohammad Fahad . Ahmad . Aamir . Bhat . Showket Hussain . Abu-Duhier . Faisel M. . Barreto . George E. . Ashraf . Ghulam Md . Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders . Neuroscience & Biobehavioral Reviews . 1 July 2019 . 102 . 95–105 . 10.1016/j.neubiorev.2019.04.003 . 30959072 . 102487049 . 28 December 2021 . en . 0149-7634.
  61. News: Men to get aneurysm screening. 6 June 2016. BBC. 5 January 2008.
  62. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC . 6 . The epidemiology of autism spectrum disorders . Annual Review of Public Health . 28 . 235–258 . 2007 . 17367287 . 10.1146/annurev.publhealth.28.021406.144007 . free .
  63. Werling . Donna M. . Geschwind . Daniel H. . Sex differences in autism spectrum disorders . Current Opinion in Neurology . April 2013 . 26 . 2 . 146–153 . 10.1097/WCO.0b013e32835ee548 . 23406909 . 4164392 .
  64. Romeo DM, Sini F, Brogna C, Albamonte E, Ricci D, Mercuri E . Sex differences in cerebral palsy on neuromotor outcome: a critical review . Developmental Medicine and Child Neurology . 58 . 8 . 809–813 . August 2016 . 27098195 . 10.1111/dmcn.13137 . free .
  65. Picchioni MM, Murray RM . Schizophrenia . BMJ . 335 . 7610 . 91–95 . July 2007 . 17626963 . 1914490 . 10.1136/bmj.39227.616447.BE .
  66. Andrew E. Skodol . Alegria AA, Blanco C, Petry NM, Skodol AE, Liu SM, Grant B, Hasin D . Sex differences in antisocial personality disorder: results from the National Epidemiological Survey on Alcohol and Related Conditions . Personality Disorders . 4 . 3 . 214–222 . July 2013 . 23544428 . 3767421 . 10.1037/a0031681 .
  67. Book: The American Psychiatric Publishing Textbook of Substance Abuse Treatment. Galanter M, Kleber HD, Brady KT . 17 December 2014. 978-1-58562-472-0. 10.1176/appi.books.9781615370030. Galanter . Marc . Kleber . Herbert D. . Brady . Kathleen T. .
  68. Book: World Cancer Report 2014. 2014. World Health Organization. 978-92-832-0429-9. 5.4 Stomach Cancer . 383–391 . .
  69. Book: 5.3 Oesophageal Cancer . Montgomery EA . 2014 . 528–543. In
  70. Hefaiedh R, Ennaifer R, Romdhane H, Ben Nejma H, Arfa N, Belhadj N, Gharbi L, Khalfallah T . 6 . Gender difference in patients with hepatocellular carcinoma . La Tunisie Médicale . 91 . 8–9 . 505–8 . Aug–Sep 2013 . 24227507 .
  71. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML . 6 . Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers . Journal of Clinical Oncology . 31 . 36 . 4550–9 . December 2013 . 24248688 . 3865341 . 10.1200/jco.2013.50.3870 .
  72. Ursin RL, Klein SL . Sex Differences in Respiratory Viral Pathogenesis and Treatments . Annual Review of Virology . 8 . 1 . 393–414 . September 2021 . 34081540 . 10.1146/annurev-virology-091919-092720 . 235333732 . free .
  73. Hertz D, Schneider B . Sex differences in tuberculosis . Seminars in Immunopathology . 41 . 2 . 225–237 . March 2019 . 30361803 . 10.1007/s00281-018-0725-6 . 53030554 .
  74. O'Driscoll DN, McGovern M, Greene CM, Molloy EJ . Gender disparities in preterm neonatal outcomes . Acta Paediatrica . 107 . 9 . 1494–9 . May 2018 . 29750838 . 10.1111/apa.14390 . 21676905 . free .
  75. Gorrell . Sasha . Murray . Stuart B. . Eating Disorders in Males . Child and Adolescent Psychiatric Clinics of North America . October 2019 . 28 . 4 . 641–651 . 10.1016/j.chc.2019.05.012 . 31443881 . 6785984 . 1558-0490.
  76. Strother . Eric . Lemberg . Raymond . Stanford . Stevie Chariese . Turberville . Dayton . Eating Disorders in Men: Underdiagnosed, Undertreated, and Misunderstood . Eating Disorders . October 2012 . 20 . 5 . 346–355 . 10.1080/10640266.2012.715512 . 22985232 . 3479631 . en . 1064-0266.
  77. Nagata . Jason M. . Ganson . Kyle T. . Murray . Stuart B. . Eating disorders in adolescent boys and young men: an update . Current Opinion in Pediatrics . August 2020 . 32 . 4 . 476–481 . 10.1097/MOP.0000000000000911 . 32520822 . 7867380 . en.
  78. Stormont . Gavin D. . Deibert . Christopher M. . Genetic causes and management of male infertility . Translational Andrology and Urology . March 2021 . 10 . 3 . 1365–72 . 10.21037/tau.2020.03.34 . 33850772 . 8039619 . en . free .
  79. Shah . K . Sivapalan . G . Gibbons . N . Tempest . H . Griffin . Dk . The genetic basis of infertility . Reproduction . 1 July 2003 . 126 . 1 . 13–25 . 10.1530/rep.0.1260013 . 12814343 . Klinefelter syndrome and the subsequent infertility phenotype caused by it are specific to males.. free .
  80. ((NCD Risk Factor Collaboration)) . Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants . Lancet . 389 . 10064 . 37–55 . January 2017 . 27863813 . 5220163 . 10.1016/S0140-6736(16)31919-5 . Web site: NCD Risk Factor Collaboration . Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants . Lancet . 15 June 2024.
  81. Izumi . Yoichi . Matsumoto . Koichi . Ozawa . Yukio . Kasamaki . Yuji . Shinndo . Atsusi . Ohta . Masakatsu . Jumabay . Madet . Nakayama . Tomohiro . Yokoyama . Eise . Shimabukuro . Hiroaki . Kawamura . Hiroshi . Cheng . Zuheng . Ma . Yitong . Mahmut . Masum . Effect of Age at Menopause on Blood Pressure in Postmenopausal Women . American Journal of Hypertension . 15 June 2024 . 1045–50 . 10.1016/j.amjhyper.2007.04.019 . 1 October 2007. 20 . 10 . 17903686 .
  82. Reckelhoff . Jane F. . Mechanisms of sex and gender differences in hypertension . Journal of Human Hypertension . 15 June 2024 . 596–601 . en . 10.1038/s41371-023-00810-4 . August 2023. 37 . 8 . 36797338 .
  83. Miller . Amanda J. . Arnold . Amy C. . The renin-angiotensin system and cardiovascular autonomic control in aging . Peptides . 170733 . 10.1016/j.peptides.2021.170733 . 1 April 2022. 150 . 34973286 . 8923940 .
  84. Reckelhoff . Jane F. . Mechanisms of sex and gender differences in hypertension . Journal of Human Hypertension . 596–601 . en . 10.1038/s41371-023-00810-4 . August 2023. 37 . 8 . 36797338 .
  85. Reckelhoff . Jane F. . Zhang . Huimin . Srivastava . Kumud . Gender Differences in Development of Hypertension in Spontaneously Hypertensive Rats: Role of the Renin-Angiotensin System . Hypertension . 480–3 . 10.1161/01.HYP.35.1.480 . January 2000. 35 . 1 . 10642345 .
  86. Miller . Amanda J. . Arnold . Amy C. . The renin-angiotensin system and cardiovascular autonomic control in aging . Peptides . 170733 . 10.1016/j.peptides.2021.170733 . 1 April 2022. 150 . 34973286 . 8923940 .
  87. Miller . Amanda J. . Arnold . Amy C. . The renin-angiotensin system and cardiovascular autonomic control in aging . Peptides . 170733 . 10.1016/j.peptides.2021.170733 . 1 April 2022. 150 . 34973286 . 8923940 .
  88. Brandt . Jessica E. . Priori . Roberta . Valesini . Guido . Fairweather . DeLisa . 2015-11-03 . Sex differences in Sjögren's syndrome: a comprehensive review of immune mechanisms . Biology of Sex Differences . 6 . 1 . 19 . 10.1186/s13293-015-0037-7 . free . 26535108 . 4630965 . 2042-6410.
  89. Xuan . Yuhao . 2024 . Impact of sex differences on the clinical presentation, pathogenesis, treatment and prognosis of Sjögren's syndrome . Immunology . 171 . 4 . 513–524 . 10.1111/imm.13740 . 38156505 .
  90. Liu . Ke . Kurien . Biji T. . Zimmerman . Sarah L. . Kaufman . Kenneth M. . Taft . Diana H. . Kottyan . Leah C. . Lazaro . Sara . Weaver . Carrie A. . Ice . John A. . Adler . Adam J. . Chodosh . James . Radfar . Lida . Rasmussen . Astrid . Stone . Donald U. . Lewis . David M. . May 2016 . X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome . Arthritis & Rheumatology . en . 68 . 5 . 1290–1300 . 10.1002/art.39560 . 2326-5191 . 5019501 . 26713507.
  91. Dou . Diana R. . 2024-02-01 . Xist ribonucleoproteins promote female sex-biased autoimmunity . Cell . 187 . 3 . 733–749 . 10.1016/j.cell.2023.12.037 . 38306984 . 10949934 . February 1, 2025 .